Granules India divests entire stake in Granules-Biocause Pharmaceutical
- Country:
- India
Granules India Ltd on Tuesday said it has divested its entire stake in Granules-Biocause Pharmaceutical Co Limited, a joint venture company located in China. Last year, Granules India had intimated about the divestment of the entire stake of the JV company for a total consideration of RMB 109 million (around Rs 110.8 crore).
"... the transaction is completed and Granules-Biocause Pharmaceutical Co Limited ceased to be the joint venture company of Granules India Limited," Granules India said in a regulatory filing. Shares of Granules India Ltd were trading at Rs 146 a piece on BSE, up 0.41 percent from the previous close.
ALSO READ
-
WTO Sets Up Panel on EU Carbon Border Rules as Russia Challenges Restrictions
-
WHO Brings Global Experts Together to Strengthen Herbal Medicine Quality and Safety
-
Human Cost of Faster Work: Chinese Employees Weigh AI’s Promise Against Pay Fears
-
China's August Disasters Yield $5.38 Billion in Losses
-
China Strengthens Military Surveillance in Djibouti
Google News